PERIOMICS CARE LLC
New York, NY · Biotech · Private
POC7a, an oral gel formulation containing a SUCNR1 antagonist molecule for treatment of periodontitis
periomicscare.com →- Grants
- $4.4M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A Novel remedy for periodontal bone loss | $224,101 | |
| Federal grant | Department of Health and Human Services · Phase I · A Novel remedy for periodontal bone loss | $224,101 | |
| Federal grant | Department of Health and Human Services · Phase I · Modulation of the gut microbiome to enhance efficacy of immunotherapy in pancreatic adenocarcinoma | $399,752 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · A Novel Remedy for Periodontal Bone Loss | $1,608,347 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · A Novel Remedy for Periodontal Bone Loss | $591,125 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Remedy for Periodontal Bone Loss | $1,017,222 | |
| Federal grant | Department of Health and Human Services · Phase I · Zinc nanocrystals from zinc tetraammine fluoride for caries arrest and remineralization | $297,711 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2121 | ARVINAS, INC. | — | $129M |
| 2122 | ARBOR EQUITY GROUP FUND I, LP | — | $500K |
| 2123 | Indapta Therapeutics Inc. | — | $84M |
| 2124 | PERIOMICS CARE LLC | — | — |
| 2125 | Apricity Therapeutics | — | — |
| 2126 | Lygos, Inc. | — | $41M |
| 2127 | SENSORIUM THERAPEUTICS INC | — | $39M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.